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ORIGINAL ARTICLE 
RAPD typing of Klebsiella pneumoniae, Klebsiella oxytoca, Serratia 
marcescens and Pseudomonas aeruginosa isolates using standardized 
reagents 
Clin Micvobiol Infect 1999; 5:  370-276 
Liesbeth Vogel, Gwendolytt Jories, Shirley Tviep, Alex Koek and Letiie Dijkshoorn 
Department of Medical Microbiology, Leiden University Medical Center, Leiden, 
The Netherlands 
Objective: To perform quality assessment of standardized random amplified polymorphic DNA (RAPD) analysis for 
epidemiologic typing of Klebsiella pneumoniae, K. oxytoca, Serratia marcescens and Pseudomonas aeruginosa. 
Methods: Thirty K. pneumoniae, 15 K. oxytoca, 30 S. marcescens and 33 F! aeruginosa epidemiologically unrelated 
isolates and four collections of clinically related isolates of each species were included in the study. RAPD analysis was 
performed using Ready-To-Go RAPD Analysis beads with primer ERIC-1R and Ready-To-Go primer 2 for K. pneumoniae 
and K. oxytoca, primer set ERIC-2/1026 and Ready-To-Go primer 2 for S. marcescens, and primers 0-10514 and D-14306 
for F! aeruginosa. 
Results: All epidemiologically unrelated K. pneumoniae and K. oxytoca isolates were distinguished. Twenty-nine types 
were distinguished among the 30 unrelated S. marcescens isolates and 32 types among the 33 unrelated F! aeruginosa 
isolates. Indistinguishable banding patterns were obtained in repeated analyses of two isolates and from 11 serial 
subcultures of three isolates of each species included in the study. The RAPD data from the clinically related isolates 
correlated with the epidemiologic origin of the isolates. 
Conclusions: The use of Ready-To-Go RAPD Analysis beads resulted in reproducible and stable banding patterns with 
a high discriminatory capacity, and the RAPD typing results corresponded with the epidemiologic origin of the isolates. 
Key words: RAPD, standardization, Klebsiella pneumoniae, Klebsiella oxytoca, Serratia marcescens, Pseudomonas 
aeruginosa 
INTRODUCTION 
Arbitrary amplification of polymorphic DNA sequences, 
termed random amplified polymorphlc DNA (RAPD) 
analysis or arbitrarily primed PCR (AP-PCR) typing 
[1,2], is a technique that is being used in many 
epidemiologic stuhes [3]. The advantage of this tech- 
nique over more traditional phenotypic typing methods 
and some more recent molecular methods, e.g. pulsed- 
field gel electrophoresis of genome macrorestriction 
fragments, is that it is rapid, relatively inexpensive and 
technically feasible for most laboratories [l]. However, 
the results obtained with this technique within and 
between laboratories do not generally show good 
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reproducibility [4-71. Therefore, in hospital epidemi- 
ology, direct analysis of previous isolates with fresh 
isolates is usually performed for comparative typing, 
rather than comparing previously obtained patterns 
with those of fresh isolates. This approach is time- 
consuming and costly. 
The observed lack of reproducibility may be a 
result of the quality of the template DNA, the 
concentrations of reagents, the DNA polymerase, the 
annealing temperature or the visuahzation technique 
[4-6,8,9]. Therefore, standardization is required. A use- 
ful step to standardization and efficiency is the use of pre- 
formulated analysis beads [lo] that contain all buffer 
ingredients, nucleotides and two DNA polymerases, 
AmpliTaq and Stoffel fragment. Only water, primer and 
template DNA have to be added to the beads before 
amplification. Since the number of pipetting steps is 
reduced by the use of these commercially available and 
quality-controlled standardized reagents, intra- and 
interlaboratory variation in the results should be dimin- 
ished, as was shown in a multicenter study investigating 
Acinetobacter isolates &om nosocomial outbreaks [ 101. 
270 
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In the present study, the quality of the standardized 
RAPD analysis data for epidemiologic typing of 
Klebsiella pneumoniae, K .  oxytoca, Serratia marcescens and 
Pseudomonas aeruginosa was investigated. These organ- 
isms are important nosocomial pathogens causing urin- 
ary tract infections, wound infections and pneumonia 
[l l-201. Resistance to antibiotics is often observed in 
these microorganisms [13,17,20-231. Therefore, fast 
and reliable typing methods to monitor the nosocomial 
spread of these microorganisms are necessary. Since 
RAPD analysis has been described as a useful method 
for epidemiologic typing of K.  pneumoniae, S. marcescens 
and I? aeruginosa isolates [ 1 8 - 2 0 , 2 ~ 8 ] ,  standardization 
of this typing method would contribute to its 
applicability in clinical microbiology. 
MATERIALS AND METHODS 
Bacteria 
The discriminatory capacity of the RAPD analysis 
method was tested with 30 K.  pneumoniae isolates, 
15 K. oxytoca isolates, 30 S. marcescens isolates and 33 
I? aeruginosa isolates. These isolates were collected from 
several hospitals in The Netherlands, the UK, Germany, 
Ireland and Spain, and were all considered to be un- 
related on the basis of their epidemiologic origin. 
The applicability of RAPD fingerprinting in clinical 
epidemiology was investigated with 24 K.  pneumoniae, 
25 K.  oxytoca, 36 S. marcescens and 41 l? aeruginosa 
isolates from 12, 13, 21 and 11 patients, respectively, 
hospitalized in the Leiden University Medical Center 
(LUMC). Within these collections, sets of isolates were 
considered clinically related either because they were 
isolated from the same patient or because they were 
isolated from patients hospitalized in the same ward 
during the same period. Epidemiologic data for these 
isolates are given in Table 1. 
Bacterial identification 
K. pneumoniae and K. oxytoca isolates were identified 
with conventional phenotypic tests [29], including 
production of acid and gas from glucose, acidification 
of lactose and mannitol, growth on citrate as a single 
carbon source, production of indole, urease and phenyl- 
alanine deaminase activity, the Voges-Proskauer test, 
and the lysine and ornithine decarboxylase test. The 
same tests were performed for identification of S. 
marcescens isolates, together with tests for acidification 
of arabinose, HBS production and DNase activity [29]. 
l? aeruginosa isolates were identified by the following 
characteristics: Gram-negative staining, positive catalase 
and oxidase tests, anaerobic growth, growth at 42°C 
and oxidative glucose metabolism [29]. 
RAPD analysis 
For RAPD-PCR analysis of K.  pneumoniae, K. oxytoca 
and l? aeruginosa isolates, crude DNA extracts obtained 
by boiling were used as template DNA. S. marcescens 
DNA was extracted with the guanidium isothiocyanate 
protocol described by Boom et a1 [30], since more and 
sharper PCR bands were obtained than with crude 
DNA extracts. Template DNA was quantified by 
comparison with known amounts of lambda-DNA on 
agarose gels containing ethidium bromide 0.5 mg/L. 
RAPD-PCR was performed by adding 50 pmol of 
primer (see below) for Klebsiella spp. or S. marcescens, or 
25 pmol of primer for I? aeruginosa, 50 ng of template 
DNA and distilled water to a final volume of 25 pL to 
one Ready-To-Go RAPD Analysis bead (Amersham 
Pharmacia Biotech, Freiburg, Germany). For typing K.  
pneumoniae and K.  oxytoca isolates, primer ERIC-1R 
(Eurogentec Nederland b.v., Maastricht, The Nether- 
lands) and Ready-To-Go primer 2 (5’-GTTTC- 
GCTCC-3’) (Amersham Pharmacia Biotech) were 
used. For typing S. marcescens isolates, primer set ERIC- 
2/1026 (5’-AAGTAAGTGACTGGGGTGAGCG-3’/ 
(Eurogentec) and Ready-To-Go primer 2 were used. 
Primers D-10514 (5’-TGGTGGCCTCGAGCAAG- 
AGAACAAAG-3’) (Eurogentec) and D-14306 (5’- 
GGTTGGGTGAGAATTGC-3’) (Eurogentec) [26,27] 
were used for RAPD analysis of l? aeruginosa isolates. 
The PCR running conditions used are listed in Table 
2. The PCRs were carried out in a ProGene Thermo- 
cycler (Techne, Cambridge, UK). 
After electrophoresis in 2% agarose gels containing 
ethidium bromide 0.5 mg/L, the DNA fragments were 
photographed with Polaroid equipment. The banding 
patterns were evaluated visually. For the purpose of this 
study, patterns with a difference of 2 2  bands were 
considered to represent different strains, while isolates 
with < 2  band difference were regarded as the same 
strain. The discriminatory capacity of the RAPD 
typing was determined by calculating Simpson’s index 
of diversity [31] from the results obtained with 
epidemiologically unrelated isolates. 
The reproducibility of the RAPD analysis was 
tested by performing at least eight repeat analyses in 
separate runs of two isolates from each species included 
in the study. 
The stability of the banding patterns was tested 
with 11 subcultures of three isolates belonging to each 
species included in the study (Figure 1). One subculture 
was frozen at -80°C and then regrown for DNA 
extraction after 6 days. One subculture was stored at 
4°C for 1 week, and three subcultures were incubated 
at 21°C for 1, 3 and 7 days, respectively. In addition, 
( 5 ’ - A T G T A A G C T C C T G G G G A T T C A C - 3 ’ )  
5 ’ - T A C A T T C G A G G A C C C C T A A G T G - 3 ’ )  
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Table 1 Epidemiologic and RAPD data for clinically related isolates 
RAPD Number of Number of 
Bacterial species pattern” isolates patients Department 
Period 
(month/ year) 
Klebsiella pneumoniae A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
K 
L 
M 
K. oxytaca 
Serratia marcescens 
A 
€3 
C 
D 
E 
F 
G 
H 
I 
J 
K 
L 
M 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
K 
L 
Pseudomonas aerugginosa A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
1 
1 
1 
1 
1 
3 
7 
I 
1 
6 
1 
1 
4 
1 
1 
1 
1 
5 
1 
2 
2 
4 
2 
7 
1
1 
1 
7 
I 
1 
1 
1 
12 
3 
2 
2 
3 
1 
8 
1 
1 
2 
4 
4 
4 
4 
4 
1 
4 
11 
3 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
5 
2 
2 
1 
2 
1 
5 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
3 
1 
Thorax 
Thorax 
Thorax 
Thorax intensive care 
Thorax intensive care 
Thorax intensive care 
Thorax intensive care 
Neurology intensive care 
Neurology intensive care 
Neurology intensive care 
Surgery intensive care 
Surgery intensive care 
Internal medicine intensive care 
Thorax intensive care 
Thorax intensive care 
Thorax intensive care 
Thorax intensive care/Thorax 
Thorax 
Neurology intensive care 
Neurology intensive care 
Neurology intensive care 
Surgery intensive care 
Surgery/Surgery intensive care 
Surgery intensive care 
Surgery intensive care 
Surgery intensive care/Thorax intensive care 
Surgery 
Surgery 
Surgery 
Surgery intensive care/Surgery 
Surgery intensive care/Surgery 
Surgery intensive care/Surgery 
Surgery intensive care 
Surgery intensive care 
Surgery intensive care 
Surgery intensive care 
Surgery intensive care 
Surgery intensive care 
Thorax 
Neurology intensive care 
Neurology intensive care/Neurology 
Kidney transplantation/Surgery intensive care 
Surgery 
Neurology intensive care 
Thorax intensive care 
Pediatric surgery 
Neonatology 
Surgery intensive care 
11 /96 
10/96 
12/96 
01/97 
08/96 
02/97 
08/96 
01/97 
01/97 
01/97 
12/96 
01/97 
01/97 
11/96 
02/97 
07/96 
01/97 
08/96 
11/96 
08/96 
08/96 
12/96 
08/96 
11/96 
11/96 
12/96 
02/96 
06/96 
12/96 
08/96 to 03/97 
11/96 
03/97 
03/96 
07/96 
08/96 
12/96 to 03/97 
02/97 
03/97 
07/97 
06/97 
06/97 to 07/97 
07/97 
07/97 
05/97 to 06/97 
05/97 
07/92 to 09/92 
06/93 
06/96 
’The RAPD patterns are coded individually for each bacterial species 
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Table 2 Primers and PCR running conditions for RAPD analysis 
Primers(s) PCR running conditions 
ERIC-1R 
Ready-To-Go 2 
ERIC-2/1026 
D-10514 
D-I4306 
2 min at 94°C 
35 cycles: 1 min at 94OC, 1 min at 25"C, 4 min at 72°C 
1 min at 94°C. 1 min at 25"C, 8 min at 7 2 T  
5 min at 95OC 
45 cycles: 1 min at 95OC, 1 min at 36"C, 2 rmn at 72OC 
2 cycles: 5 min at 9 4 T ,  5 min at 35T ,  5 min at 72OC 
31 cycles: 1 min at 94T ,  1 min at 6OoC, 2 min at 72°C 
8 min at 72°C 
45 cycles: 1 min at 94"C, 1 min at 4 5 T ,  2 min at 72°C 
10 min at 72°C 
45 cycles: 1 min at 94"C, 1 min at 45T,  2 min at 72°C 
10 min at 72OC 
-80°C 
v 
35°C t 4" DNA 
L t  21°C 1 I DNA 
DNA t :::$c. 35°C t4"C t 35"Ct 3 5 ° C ~  35"Cb 35OCt35"Ct DNA 
t DNA I DNA I 1 DNA DNA 
-80°C t 3 5 -  "C DNA 
Figure 1 Scheme of the subculturing protocol performed with three isolates belonging to each species included in the 
study. b , subculturing; DNA, preparation of template DNA. 
each isolate was tested after one, two and four sub- 
cultures and after subsequent storage at 4°C for 2 days; 
this was followed by further analysis after one, two and 
five subcultures. 
RESULTS 
An average of seven bands per pattern was generated 
with the Ready-To-Go RAPD beads. Thirty different 
banding patterns were distinguished for the 30 epi- 
demiologically unrelated K. pneumoniae isolates and 15 
different banding patterns for the 15 K. oxytocu isolates, 
with either primer ERIC-1 or Ready-To-Go primer 2 
(Simpson's index of diversity= 1) (Figure 2). For the 30 
epidemiologically unrelated S. marcescens isolates, 24 
banding patterns were distinguished with Ready-To- 
Go primer 2 (Simpson's index of diversity=0.97), and 
26 banding patterns with primer set ERIC-2/1026 
(Simpson's index of diversity=0.99) (Figure 3).  O n  
combination of the results obtained with Ready-To- 
Go primer 2 and primer set ERIC-2/1026, 39 types 
were distinguished among the 30 epidemiologically 
unrelated S. murcescens isolates (Simpson's index of 
diversity= 1 .O). For the 33 unrelated I? aeruginosa 
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Figure 2 Examples of banding patterns obtained with (A) K. pneumoniae isolates using primer ERIC-1 (lanes 1-5) or 
Ready-To-Go primer 2 (lanes 6-10), and (B) K. oxytoca isolates using primer ERIC-1 (lanes 1-5) or Ready-To-Go primer 
2 (lanes 6-10). 
Figure 3 Examples of banding patterns obtained with S. 
marcescens isolates using Ready-To-Go primer 2 (lanes 1-5) 
or primer set ERIC-2/1026 (lanes 6-10), 
Figure 4 Examples of banding patterns obtained with l? 
aeruginora isolates using primer D-10514 (lanes 2-5) or 
primer D-14306 (lanes 6-10), 
isolates, 32 banding patterns were distinguished with 
either primer D-10514 or primer D-14306 (Simpson's 
index of &versity=0.99) (Figure 4), and if the results 
obtained with both primers were combined, 33 types 
were distinguished (Simpson's index of diversity= 1.0). 
For each species included in the study, the banding 
patterns obtained with both primers or primer sets in 
repeated analyses of selected isolates and from serial 
subcultures were indistinguishable (data not shown). 
Correlation of the FUPD data with the epidemio- 
logic origin of the isolates of K. pneumoniae, K. oxytoca, 
S. marcescens and l? aeruginosa was tested with sets of 
clinically related isolates from several patients (Table 1). 
Of the 12 patients with multiple K. pneumoniae or K. 
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oxytora isolates, 11 yielded isolates with no banding 
pattern variations. One patient yielded K. pneumoniae 
isolates with two distinct patterns (patterns L and M, 
Table 1). Patterns of K .  pneumoniae and K. oxytoca 
isolates from different patients hospitalized in the same 
departments showed no similarity. Similar banding 
patterns were observed within the sets of S. marcescens 
isolates from 19 patients. Two patients yielded isolates 
with two distinct banding patterns (patterns F and J and 
patterns D and F, Table l), while three patterns were 
similar in the S. marcescens isolates from two patients, 
and two patterns were similar in the S. marcescens 
isolates from five patients. One patient yielded l? 
aeruginosa isolates with two banding patterns (patterns 
G and H, Table 1). No banding pattern variations were 
observed in the sets of l? aeruginosa isolates from the 
remaining patients, and three patients yielded l? 
aeruginosa isolates with the same banding pattern. 
DISCUSSION 
This study assessed the quality of the standardized 
RAPD analysis data for epidemiologic typing of K. 
pneumoniae, K. oxytoca, S. marcescens and l? aeruginosa 
isolates. The discriminatory capacity, calculated as 
Simpson's index of diversity, was >0.95, indicating that 
RAPD analysis with Ready-To-Go beads may be used 
as a single typing method. Struelens et a l  [32] recom- 
mended the use of 100 strains for testing the dis- 
criminatory capacity of a typing method. In the present 
study, only 30 strains were used, as it was considered 
that this number was sufficient for the purpose of this 
study. As in a previous study [9], isolates with a 
difference of 22  bands were regarded as different for 
practical reasons, although the significance of a band 
difference naturally depends on the total number of 
bands in the pattern. 
The indistinguishable banding patterns obtained 
with repeated analyses of two isolates fiom each species 
included in the study demonstrated that RAPD analysis 
using Ready-To-Go beads is a reproducible method for 
typing K .  pneumoniae, K. oxytoca, S. marcescens and l? 
aeruginosa isolates. Moreover, the banding patterns were 
not influenced by subculturing or storage conditions, 
since no differences were observed between the band- 
ing patterns from the subcultures of each isolate. 
The results obtained with clinically related isolates 
showed that RAPD analysis of K. pneumoniae, K. 
oxytoca, S. marcescens and l? aeruginosa was applicable in 
clinical epidemiology, since the typing data correlated 
with the epidemiologic origin of the isolates. Sets of 
isolates from all patients, except four, showed a similar 
banding pattern within each set, supporting the 
assumed clinical relatedness of the isolates within each 
set. The four patients who yielded isolates with 
different banding patterns were apparently infected 
with different strains. The RAPD data obtained from 
clinically related Klebsiella isolates indicated that these 
bacteria were not transmitted between patients in the 
intensive care wards and the thorax department, since 
the banding patterns of the isolates from different 
patients showed no similarity. In contrast, the fact that 
clinically related S. marcescens isolates with the same 
banding patterns were obtained from several patients 
indicated possible endemic spread of these bacteria in 
the surgical wards. Patients frequently moved from the 
surgery intensive care unit to the surgery ward, and 
three apparently indistinguishable S. marcescens isolates 
were found in both departments. The similar banding 
patterns of l? aeruginosa isolates (pattern b, Table 1) from 
three patients in the neonatology department also 
indicated endemic spread of these bacteria in this 
department. Thus, RAPD analysis seems to be a useful 
tool for assessing epidemiologic relationships of these 
microorganisms, although results from other compar- 
ative typing methods would be required to reach 
definitive conclusions on strain identity. 
In conclusion, use of Ready-To-Go RAPD Analysis 
beads resulted in reproducible and stable RAPD 
banding patterns, which were clearly interpretable and 
had a high discriminatory capacity. In addition, the 
RAPD data obtained were found to correspond with 
the epidemiologic origin of the isolates. Considering 
the ease of use of Ready-To-Go RAPD Analysis beads, 
these commercially available standardized reagents seem 
to provide a step forwards in the applicability of RAPD 
fingerprinting in diagnostic microbiology. Moreover, 
since the use of Ready-To-Go RAPD Analysis beads 
also contributes to inter-laboratory reproducibility 
[lo], RAPD fingerprinting may become applicable in 
larger epidemiologic studies in which RAPD data are 
exchanged between different laboratories. 
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